Liraglutide, a GLP-1 significantly lowers the rate of recurrent stroke in patients with diabetes, with no apparent increase ...

The absolute risk for thyroid cancer is low among patients receiving glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy.

Sodium-glucose cotransporter 2, or SGLT2, inhibitors and glucagon-like peptide-1 receptor ... their operations or governance structure. Women prescribed a GLP-1 receptor agonist up to 2 years ...

Glucagon-like peptide-1 receptor agonist medications for weight loss are significantly transforming the field of facial plastic surgery.

Insulin-like growth factor (IGF) 1 is ... receptor can form heterodimers that bind both ligands IGF1 has actions distinct from those of growth hormone in carbohydrate, lipid and protein metabolism ...

A game-changer for obesity and heart failure? Dr Pandey reveals breakthrough GLP-1 trial results that show reduced cardiovascular risk and better outcomes for HFpEF patients. Don’t miss this!

A new review reports that nine people taking semaglutide and tirzepatide — the active ingredient in GLP-1 medications — ...

Using the Hubble Space Telescope (HST), astronomers have observed a supermassive galactic open cluster designated Westerlund ...

After hours: 7:48:49 p.m. EST ...